Gd(III) complexes of 1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid bearing two and four hydroxymethyl moieties on the cyclen ring were prepared to be studied as low toxicity MRI contrast agents. The key intermediates in the syntheses of the two ligands are the corresponding bis and tetras
One example of useful disorder : Structure of Pr(III) complex of 1,4,7,10-tetraazacyclododecane-10-methyl-1,4,7-tris(methylenephenylphosphinic) acid
✍ Scribed by Jana Klimentová; Pavel Vojtı´šek
- Publisher
- Elsevier Science
- Year
- 2007
- Tongue
- English
- Weight
- 354 KB
- Volume
- 826
- Category
- Article
- ISSN
- 0022-2860
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
1,4,7-Tris(tert-butoxycarbonylmethyl)-1,4,7,10-tetraazacyclododecane is widely used as an intermediate in the preparation of medically important DO3A and DOTA metal chelators. Despite its commercial availability and importance, the literature describing the preparation and properties of the free bas
## Abstract The protonation constants of 2‐[4,7,10‐tris(phosphonomethyl)‐1,4,7,10‐tetraazacyclododecan‐1‐yl]acetic acid (H~7~DOA3P) and of the complexes [Ln(DOA3P)]^4−^ (Ln=Ce, Pr, Sm, Eu, and Yb) have been determined by multinuclear NMR spectroscopy in the range pD 2–13.8, without control of ionic